AI-generated summary
The authors compared a three-wavelength LED device (633 and 830 nm) with intense pulsed light for reducing facial hypervascularization in 20 adults in a single-center, open-label, proof-of-concept study. They report moderate improvement with LEDs, marked improvement with IPL in most patients, and that LED treatment caused no pain while all IPL patients reported severe pain. The authors describe the LED treatment as effective and well tolerated, but the small, open-label design is a significant limitation.
- Participants
- 20
- Who or what was studied
- Adult patients with superficial facial hypervascularization (20 total, 10 per group)
- Wavelengths
- 633, 830, 555, 950, 530, 750 nm
- Limits stated in the abstract
- The study was small, single-center, open-label and proof-of-concept, with no control group and no randomization.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm, 530-750 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.